Vicarious Surgical (RBOT) Interest & Investment Income (2020 - 2025)
Vicarious Surgical (RBOT) reported Interest & Investment Income of $158000.0 for Q3 2025, down 80.3% year-over-year from $802000.0 in Q3 2024, and down 40.15% quarter-over-quarter from $264000.0 in Q2 2025.
Vicarious Surgical (RBOT) Interest & Investment Income (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has 6 years of Interest & Investment Income data on file, last reported at $158000.0 in Q3 2025.
- Interest & Investment Income for Q3 2025 came in at $158000.0, down 80.3% year-over-year; the trailing twelve-month figure through Sep 2025 was $1.5 million (down 60.07% YoY), and the FY2024 annual result was $3.3 million, down 25.74% from the prior year.
- Interest & Investment Income fell to $158000.0 in Q3 2025 per RBOT's latest filing, from $264000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $1.5 million in Q1 2023 and troughed at -$1000.0 in Q3 2021.
- A 5-year average of $528473.7 and a median of $494000.0 in 2022 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2021 and 2022: Interest & Investment Income plunged 200.0% in 2021, then surged 49500.0% in 2022.
- A 5-year view of Interest & Investment Income shows it stood at $19000.0 in 2021, then jumped by 4278.95% to $832000.0 in 2022, then gained by 16.11% to $966000.0 in 2023, then slumped by 38.51% to $594000.0 in 2024, then plunged by 73.4% to $158000.0 in 2025.
- Business Quant data shows RBOT's Interest & Investment Income at $158000.0 in Q3 2025, $264000.0 in Q2 2025, and $446000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 33.50 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | - |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 40.98 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Vicarious Surgical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 158,000.00 |
| Jun 30, 2025 | 264,000.00 |
| Mar 31, 2025 | 446,000.00 |
| Dec 31, 2024 | 594,000.00 |
| Sep 30, 2024 | 802,000.00 |
| Jun 30, 2024 | 918,000.00 |
| Mar 31, 2024 | 975,000.00 |
| Dec 31, 2023 | 966,000.00 |
| Sep 30, 2023 | 946,000.00 |
| Jun 30, 2023 | 1.04 Mn |
| Mar 31, 2023 | 1.47 Mn |
| Dec 31, 2022 | 832,000.00 |
| Sep 30, 2022 | 494,000.00 |
| Jun 30, 2022 | 101,000.00 |
| Mar 31, 2022 | 8,000.00 |
| Dec 31, 2021 | 19,000.00 |
| Sep 30, 2021 | -1,000.00 |
| Jun 30, 2021 | 1,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Dec 31, 2020 | -1,000.00 |